Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 01345P106
Event date: 2022-09-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-22-002111
- Form type
- SC 13G
- Filer
- ALBIREO PHARMA, INC.
- CIK
- CIK 1322505
- Filed
- Oct 03, 2022
- Reporting period
- Sep 23, 2022
- Description
- Schedule 13G beneficial ownership